SCHEMBL27740430

SCHEMBL27740430

NC(=O)c1cccnc1S(=O)(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.51
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
MAPT P10636 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
AHR P35869 1/20 0.43
NAPRT Q6XQN6 1/20 0.43
P2RX7 Q99572 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
BLM P54132 1/20 0.40
AGER Q15109 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213767 0.85 PARP1 (0.51) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL9953506 0.84 PARP1 (0.50) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL9569309 0.84 PARP1 (0.50) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL21449055 0.83 KDM4E (0.57) KDM4EALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL31368390 0.80 PARP1 (0.46) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL9955204 0.78 PARP1 (0.45) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30712181 0.77 SMN1; SMN2 (0.41) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL27996476 0.77 KDM4E (0.48) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL29082826 0.76 P2RX7 (0.62) PARP1KDM4EALDH1A1HPGDHSD17B10
Methyl Alcohol SCHEMBL27853401 0.76 TDP1 (0.50) KDM4EALDH1A1HSD17B10TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101802599-A reagent devices HOFFMANN LA ROCHE 2010-08-11 CN disclosed
CN-101273015-A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes NOVARTIS AG (CH) 2008-09-24 CN disclosed
CN-101273048-A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes NOVARTIS AG (CH) 2008-09-24 CN disclosed